Fierce Pharma Biopharma News & Insights
Fierce Pharma delivers breaking news and analysis about drug companies, the FDA and the broader pharma industry, including manufacturing, marketing and finance.
Pharma | Fierce Pharma
6 days ago · Bristol Myers Squibb vet Catherine Owen Adams joined Acadia months after the company gave up on a years-long mission to expand its label for Nuplazid.
Fierce's forecasts for the next year in biopharma
1 day ago · This week on “The Top Line,” we explore the trends that defined biopharma in 2024 and predict how 2025 might shake out for the industry.
AZ's Calquence, Amgen's Lumakras win new FDA green lights
2 days ago · The latest nod converts the FDA’s previously granted accelerated approval for MCL patients treated with at least one prior therapy to a full one and adds to Calquence’s breadth of …
2024 approvals: Biopharma delivered 55 new drugs, biologics
Jan 2, 2025 · The FDA signed off on 55 new drugs in 2024, down from 60-plus in 2023.
Fierce 50 of 2024 | Fierce Pharma
Sep 9, 2024 · I’m honored to introduce the second edition of the Fierce 50, where we once again spotlight the innovators and leaders driving the future of healthcare, pharma and biotech. This year’s ...
Recapping Fierce Pharma's top stories of the year
Dec 23, 2024 · With top stories No. 4 and No. 6 of the year, you’ll again see the reader's enthusiasm for GLP-1 drug launches. Both pieces focused on the overwhelming demand for …
Fierce 50 | Fierce Pharma
Jan 22, 2024 · This week on "The Top Line," we bring you a special conversation from our New York City gala, where we celebrated this year’s Fierce 50 honorees.
Biotech - Fierce Pharma
Dec 16, 2024 · In a phase 3 trial, Tenpoint’s recently acquired eye drop—a combination of carbachol and brimonidine—improved vision for patients with presbyopia.
Executives - Fierce Pharma
Oct 22, 2024 · The changing COVID and RSV vaccine markets required Moderna to change part of its financial framework, CEO Stéphane Bancel explained to shareholders.